Legend Biotech Files Q1 2025 6-K with Financial Data
Ticker: LEGN · Form: 6-K · Filed: May 13, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-update, 6-K, quarterly-filing
TL;DR
Legend Biotech dropped its Q1 2025 financials, showing equity and reserve changes.
AI Summary
Legend Biotech Corp. filed a 6-K report on May 13, 2025, for the period ending March 31, 2025. The filing includes financial data for the first quarter of 2025 and the full year 2024, detailing various equity and reserve accounts. Specific figures for issued capital, share premium, reserves for share-based payments, and retained earnings are presented for comparative periods.
Why It Matters
This filing provides investors with an update on Legend Biotech's financial position as of the end of Q1 2025, allowing for analysis of equity and reserve movements.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) providing an update on financial statement information.
Key Numbers
- 2025 Q1 — Reporting Period (Financial data presented for the first quarter of 2025.)
- 2024-12-31 — Previous Year End (Comparative financial data from the end of 2024.)
Key Players & Entities
- Legend Biotech Corp. (company) — Filer of the report
- 0001801198-25-000021 (filing_id) — Accession number for the filing
- 20250513 (date) — Filing date
- 20250331 (date) — Period of report
FAQ
What specific financial statements are included in this 6-K filing?
The filing includes financial data related to issued capital, share premium, reserves for share-based payments, reserves for exchange differences on translation, and retained earnings for various periods, including Q1 2025 and year-end 2024.
What is the filing date of this 6-K report?
The filing date is May 13, 2025.
What is the period of report for this 6-K filing?
The period of report is March 31, 2025.
What is the Central Index Key (CIK) for Legend Biotech Corp.?
The Central Index Key for Legend Biotech Corp. is 0001801198.
What is the Standard Industrial Classification (SIC) code for Legend Biotech Corp.?
The Standard Industrial Classification code for Legend Biotech Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 13, 2025 regarding Legend Biotech Corp (LEGN).